Crown Aesthetics Unveils FDA-Cleared SkinPen Precision Elite
![Crown Aesthetics Unveils FDA-Cleared SkinPen Precision Elite](https://investorshangout.com/images/blog/ihnews-Crown%20Aesthetics%20Unveils%20FDA-Cleared%20SkinPen%20Precision%20Elite.jpg)
Introduction to SkinPen Precision Elite
Crown Aesthetics, a subsidiary of Crown Laboratories, has made a significant stride in the dermatologic and aesthetics medical device space by announcing the FDA clearance of their latest innovation, the SkinPen Precision Elite. As the first FDA-cleared microneedling treatment, SkinPen has established itself as a leader in its field. The launch of this new device signifies a continuation of the brand's commitment to excellence and innovation in aesthetic treatments.
Advanced Features of SkinPen Precision Elite
The SkinPen Precision Elite is engineered to elevate the user experience and improve treatment outcomes. Among its new features are:
- Easy-to-install RFID cartridges for convenience.
- Enhanced safety features that prioritize patient protection.
- Active retraction technology developed under the novel ActiSine™ system.
- A lifetime warranty, subject to terms and conditions, ensuring reliability and longevity.
This upgraded device not only aims to augment provider satisfaction but also enhances the results and experiences for patients.
Market Launch and Anticipation
Following its initial FDA-clearance six years ago, the SkinPen has become the preferred choice for microneedling procedures across the U.S. The SkinPen Precision Elite is set to launch in the near future, providing aesthetic practices with a premium option tailored to meet the needs of their clientele. This move is expected to further cement Crown Aesthetics's reputation in the industry.
Voices from Leadership and Experts
Jeff Bedard, the Founder and CEO of Crown Laboratories, expressed enthusiasm for the new product, stating, "We look forward to bringing the FDA-cleared SkinPen Precision Elite to market as a premium option for our trusted aesthetics partners. Our commitment to enhancing the provider experience and patient outcomes is unwavering."
Dr. Doris Day, a Board-Certified Dermatologist, commended the brand’s dedication, noting, "Microneedling with SkinPen is an effective method that leverages the body's natural healing to improve the appearance of acne scars and wrinkles."
Significance of Microneedling
Microneedling has emerged as a powerful treatment for individuals seeking skin rejuvenation. By stimulating collagen production, it supports the body's natural healing processes, leading to improvements in skin texture and appearance. The SkinPen Precision Elite uniquely enhances this procedure, making it a sought-after option for both practitioners and patients.
About Crown Aesthetics
Crown Aesthetics is a highly regarded medical aesthetics company focused on driving significant growth within leading practices across the globe. Their innovative offerings, which include the original SkinPen, MicroPen EVO™, and other advanced systems, serve as gateways for attracting new patients who value effective and reliable aesthetic solutions. Based in Dallas, Texas, the company is dedicated to setting industry benchmarks for efficacy, safety, and innovation.
About Crown Laboratories, Inc.
Crown Laboratories is a privately held global skincare company that specializes in developing a wide array of aesthetic, therapeutic, and premium skincare products aimed at improving the lives of consumers. Recognized for its commitment to skin science, Crown is dedicated to achieving therapeutic excellence and enhancing patient outcomes. The company has consistently been honored on the Inc. 5000 Fastest Growing Privately Held Companies List and has expanded its operations to over 60 countries worldwide.
Frequently Asked Questions
What is SkinPen Precision Elite?
SkinPen Precision Elite is the latest FDA-cleared microneedling device from Crown Aesthetics, designed to enhance treatment experiences and outcomes.
How does microneedling benefit the skin?
Microneedling stimulates collagen production, which can help improve skin texture, reduce scars, and diminish wrinkles.
When will SkinPen Precision Elite be available?
The SkinPen Precision Elite is anticipated to launch later this year, offering advanced features to aesthetic practices.
Who is Crown Aesthetics?
Crown Aesthetics is a leading medical aesthetics company that focuses on innovative products for aesthetic practices worldwide.
What other products does Crown offer?
In addition to SkinPen, Crown Aesthetics offers products like MicroPen EVO™ and BIOJUVE™, designed for effective skin rejuvenation.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- 2025 Nissan Armada Unveils Exclusive Klipsch Audio System
- Beeyou.tv Unveils New Features for Creators at IBC 2024 Event
- Bluetooth SIG Unveils Innovating Distance Awareness Features
- Jeremiah's Italian Ice Unveils Exciting Tadpole Mini Treat
- Wipfli Unveils 2024 Annual Report Detailing Growth and Innovation
- Exdion Insurance Unveils CSRdigit: Revolutionizing E&O Protection
- Agmatix Unveils RegenIQ: Revolutionizing Regenerative Agriculture
- Tiny Traveler Unveils Advanced AI Baby Monitor for Parents
- Eton Solutions Unveils EtonGPT™, Revolutionary AI for Family Offices
- Cleartide Unveils Stylish and Efficient Condensate Pumps
- Cemat A/S Unveils Managerial Share Transactions Update
- Baker Hughes Unveils Leadership Changes for Future Growth
- Yukon Metals Unveils Promising Gold and Copper Discovery
- Plumas Bank Unveils 2024 Corporate Citizenship Insights
- G2 Goldfields Unveils Exciting Drilling Results at OKO
- Krispy Krunchy Chicken® Unveils Exciting $4 Meal Deal
- Brillo Hair Care Unveils Innovative Detox Scalp Mask for Healthier Hair
- Rob Faw Unveils Leadership Strategies for Today's Challenges
- Crown Electrokinetics Advances Smart Water Solutions
- The Cancer & Hematology Centers Unveils New Clinic in Grand Rapids
- Elevai Labs Inc. Unveils Promising Hair Restoration Data
- Praxis Precision Medicines Shares Promising EMBOLD Study Results
- Altimmune Unveils Pemvidutide Clinical Data at Diabetes Meeting
- InflaRx Unveils Promising Preclinical Findings for INF904
- Cheer Holding Unveils AI-Powered Series: Liaozhai Tales
Recent Articles
- Farm Aid 2024 Media Credential Deadline Approaching Soon
- Insightec Welcomes Jake Ghannam as Chief Commercial Officer
- Specialty Fertilizers Market Set to Reach USD 54.2 Billion Soon
- Brazil Senate Delays Galipolo's Central Bank Confirmation Vote
- Ademi LLP Investigates SPAR Group's Transaction Fairness for Shareholders
- Exploring High-Paying Tech Jobs Without a Degree Path
- Nickelodeon Welcomes Modern Family to Nick at Nite Lineup
- Generix Innovates with Major Investment in AI Technology
- Aker ASA Finalizes Aker BioMarine Feed Ingredients Deal
- DMEX.APP Launches Cross Margin Positions for Traders
- RushMyPassport: Empowering Travelers in September Awareness Month
- GSE Worldwide Receives Strategic Investment to Fuel Growth
- Lerner Publishing Group Expands Portfolio with New Acquisition
- Object Management Group Launches New Journal of Innovation
- Ignitis Group Commits to 174 MW Tume Solar Project
- dxFeed Partners with PriceSquawk to Enhance Trading Experience
- Schwab Insights: Boost Your Retirement Savings Effectively
- Vislink Technologies Welcomes Joseph Lipowski as CTO
- 4DMT Engages at 2024 Cantor Global Healthcare Conference
- Clene Inc. Prepares for H.C. Wainwright Investment Event
- Illumina's Legal Win Against EU Sets New Merger Precedents
- NRx Pharmaceuticals and HOPE Therapeutics to Present at Conference
- Dimethyl Terephthalate Market Growth and Future Outlook
- Abeona Therapeutics Engages Investors at Upcoming Conferences
- Praxis Precision Medicines Shares Promising EMBOLD Study Results